An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers.

BMC Cancer · 2020 · PMC7068944 · PMID 32164626

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This data was highly significant suggesting that the immune environment of sporadic breast and ovarian cancers in our cohort was much more active relative to that of carriers of germline mutations in BRCA1/2 genes.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.